Study Overview
Sex: All
Age: 18 Years to 60 Years (Adult)
Accepts Healthy Volunteers? yes
Study Documents
Study Protocol Statistical Analysis PlanStudy Overview
Sex: All
Age: 18 Years to 60 Years (Adult)
Accepts Healthy Volunteers? yes
BGB-DXP593-101
Completed
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
Beigene Study ID
BGB-DXP593-101
ClinicalTrials.gov ID
Sex: All
Age: 18 Years to 60 Years (Adult)
Accepts Healthy Volunteers? yes
Sex: All
Age: 18 Years to 60 Years (Adult)
Accepts Healthy Volunteers? yes
BeiGene provides links to web sites of other organizations in order to provide visitors with certain information. A link does not constitute an endorsement of content, viewpoint, policies, products or services of that web site. Once you link to another web site not maintained byBeiGene Australia, you are subject to the terms and conditions of that web site, including but not limited to its privacy policy.
Click the link above to continue or CANCEL